Feasibility of Music Therapy for Spontaneous Breathing Trials

Sponsor
Medical University of South Carolina (Other)
Overall Status
Recruiting
CT.gov ID
NCT05008328
Collaborator
(none)
80
1
2
14
5.7

Study Details

Study Description

Brief Summary

In this study, the investigators will study music therapy for patients during breathing trials, a procedure performed in intensive care units. Participants will be assigned either to standard medical care or standard medical care plus music therapy. Participants have a 50/50 chance (like flipping a coin) of being in either group. In the music therapy group, a board-certified music therapist will sing softly with guitar accompaniment to provide music during the breathing trial. The music is in addition to the usual treatment provided by hospital staff. Participants in the standard medical care group will receive the usual medical care given by hospital staff members. Information will be collected from participant's charts and by observation of vital signs during the breathing trial.

Condition or Disease Intervention/Treatment Phase
  • Other: Music therapy plus standard care during an SBT
  • Procedure: Standard care during an SBT
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Feasibility of Live, Receptive Music Therapy for Patients Undergoing Spontaneous Breathing Trials: A Pilot Study
Actual Study Start Date :
Aug 30, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Oct 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Music Therapy plus Standard Care

Music therapy intervention in addition to standard hospital care during an SBT.

Other: Music therapy plus standard care during an SBT
If the participant is randomly assigned to standard care plus music therapy, a music therapist will enter the room five minutes prior to the start of the breathing trial and begin to play quiet music on a guitar. The nurse will reduce medicine to bring the participant to an alert state. The music therapist will introduce themselves and the music intervention, and will continue to play quiet guitar music and sing softly while the respiratory therapist begins the breathing trial. The music therapist will continue playing and singing for 20 minutes into the breathing trial.

Active Comparator: Standard Care

Standard hospital care during an SBT.

Procedure: Standard care during an SBT
The patient's nurse will reduce sedatives so the patient is alert and awake. The respiratory therapist will introduce themselves to the patient and inform them of the SBT, stating they will turn off the ventilator machine and allow the patient to breathe independently. The respiratory therapist will switch off the ventilator and leave the room. The respiratory therapist and nurse will both be available throughout the SBT, and the ventilator will automatically turn on if the patient stops breathing. The SBT will last for 30-60 minutes.

Outcome Measures

Primary Outcome Measures

  1. Proportion of successful initial spontaneous breathing trials (SBTs) vs failed initial SBTs [Up to 48 hours after the participant's initial SBT.]

    A successful SBT is defined as when a patient sustains at least 30 minutes without mechanical ventilator support, as deemed by the respiratory therapist in the participant's chart. A failed SBT is defined as when a patient requires mechanical ventilator support within 30 minutes of the start of the SBT, as deemed by the respiratory therapist.

Secondary Outcome Measures

  1. Mean minutes sustained off ventilator support for failed SBTs [Up to 48 hours after the participant's initial SBT.]

    Total minutes sustained off ventilator support, as noted by respiratory therapist in the participant's chart.

  2. Mean score of heart rate at points throughout SBT [At minute 0 of the SBT, 10 minutes into the SBT, and 30 minutes into the SBT]

    Recording of patient's heart rate via observation of monitor at three points throughout the SBT

  3. Mean score of respiratory rate at points throughout SBT [At minute 0 of the SBT, 10 minutes into the SBT, and 30 minutes into the SBT]

    Recording of patient's respiratory rate via observation of monitor at three points throughout the SBT

  4. Mean score of blood pressure at points throughout SBT [At minute 0 of the SBT, 10 minutes into the SBT, and 30 minutes into the SBT]

    Recording of patient's blood pressure via observation of monitor at three points throughout the SBT

  5. Mean score of agitation as assessed by the Richmond Agitation-Sedation Scale at points throughout SBT [At minute 0 of the SBT, 10 minutes into the SBT, and 30 minutes into the SBT]

    4 Combative- Overtly combative, violent, immediate danger to staff 3 Very agitated- Pulls or removes tube(s) or catheter(s); aggressive 2 Agitated- Frequent non-purposeful movement, fights ventilator 1 Restless- Anxious but movements not aggressive vigorous 0 Alert and calm 1 Drowsy- Not fully alert, but has sustained awakening (eye opening/contact) to voice (>10 seconds) 2 Light sedation- Briefly awakens with eye contact to voice (<10 seconds) 3 Moderate sedation- Movement or eye opening to voice (but no eye contact) 4 Deep sedation- No response to voice, but movement or eye opening to physical stimulation 5 Unarousable- No response to voice or physical stimulation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults 18+

  • Admitted to MUSC's Main Hospital medical intensive care unit (MICU) or Ashley River Tower medical-surgical intensive care unit (MSICU)

  • Intubated and will undergo a spontaneous breathing trial

Exclusion Criteria:
  • Patients who have had any prior SBTs

  • Patients known to have a neurological injury

  • Patients who are known to be deaf

  • Patients whom (or whose LAR) are unable or unwilling to give informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Medical University of South Carolina

Investigators

  • Principal Investigator: Macel Reising, MT-BC, Medical University of South Carolina

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Macel Reising, Music Therapist, Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT05008328
Other Study ID Numbers:
  • Pro00110030
First Posted:
Aug 17, 2021
Last Update Posted:
Jan 11, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2022